Reflux and epigastric pain. Gastro-oesophageal reflux disease
Conditions
Interventions
Intervention 1: intervention group:
Rabeprazol Sodium (Iran Najo, 20 mg Entereic coated) will be administered the night before surgery. Intervention 2: Control Group:
Ranitidine (tablet, 150mg, Arya C
Treatment - Drugs
intervention group:
Rabeprazol Sodium (Iran Najo, 20 mg Entereic coated) will be administered the night before surgery.
Control Group:
Ranitidine (tablet, 150mg, Arya Co. Iran) will be administered the night before surgery.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: ASA status I patients scheduled for elective vitrectomy surgery Exclusion Criteria: Patients with gastrointestinal diseases and those receiving medication that may have altered gastric motility were excluded from the study. addiction, pregnancy, psychological disorders, BMI above 35
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Epigastric Pain. Timepoint: 1, 2, 4 hour after surgery. Method of measurement: visual analog scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Burn. Timepoint: 1,2,4 Hours after surgery. Method of measurement: Questionnaire (yes/no). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactValiollah Hassani
Tehran University of Medical Sciences
Outcome results
None listed